• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
CAJ
Click for more information
0.00% 38.0¢

CAPITOL HEALTH LIMITED - Announcements

Market Cap $341.1M  ! watchlist Created with Sketch. Add to my watchlist

Capitol Health Limited is an Australia-based company, which is engaged in providing the... Capitol Health Limited is an Australia-based company, which is engaged in providing the diagnostic imaging and related services to the Australian healthcare market. The Company owns and operates clinics throughout Victoria, Tasmania, South Australia, and Western Australia. Its operational focus is on delivering a community-based infrastructure for radiologists and related medical practitioners to deliver optimal, efficient, accurate healthcare service outcomes for patients. Its businesses operate under the brands Capital Radiology, Imaging at Olympic Park, Radiology Tasmania, Fowler Simmons Radiology, Women’s Imaging, FMIG and Direct Radiology. The Company manages the needs of patients requiring diagnostic imaging and interventional services, including general X-rays, ultrasounds, computed tomography (CT) and magnetic resonance imaging (MRI), and specialized services, such as mammography, echocardiography, nuclear medicine, cardiac imaging, and specialty musculoskeletal procedures.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW

Filter Results
All Price Sensitive Only
search Created with Sketch. Search
search Created with Sketch. Search
CAJ Update on Sale of NSW AssetsPRICE SENSITIVE19/07/17
CAJ Change in substantial holding from WMI29/06/17
CAJ Change in substantial holding from WAM26/06/17
CAJ Change in substantial holding from WAA26/06/17
CAJ Restructuring and Management ChangesPRICE SENSITIVE16/06/17
CAJ Sale of NSW Assets for $81.5m and GuidancePRICE SENSITIVE14/06/17
CAJ Becoming a substantial holder from WAM15/05/17
CAJ Becoming a substantial holder from WAA15/05/17
CAJ Enlitic Wins 1 Million Euro Cube Tech Fair Competition15/05/17
CAJ Response to Federal Budget Measures10/05/17
CAJ Ceasing to be a substantial holder18/04/17
CAJ Market UpdatePRICE SENSITIVE18/04/17
CAJ Becoming a substantial holder13/04/17
CAJ Becoming a substantial holder from AEF13/04/17
CAJ Placement & SPP Allotment Completed, 3B & Cleansing Notice11/04/17
CAJ Results of Extraordinary General Meeting05/04/17
CAJ Enlitic, Capitol & Paiyipai Collaborate in ChinaPRICE SENSITIVE03/04/17
CAJ Share Purchase Plan Scale-Back Refund28/03/17
CAJ Share Purchase Plan Oversubscribed22/03/17
CAJ Waiver from Listing Rule 14.714/03/17
CAJ S&P DJ Indices Announces March Quarterly RebalancePRICE SENSITIVE10/03/17
CAJ Notice of Extraordinary General Meeting02/03/17
CAJ SPP Offer DocumentPRICE SENSITIVE02/03/17
CAJ Cleansing Notice02/03/17
CAJ Market Presentation - Results, Capital Raising and SPP28/02/17
CAJ $38.5m Capital Raising to Reduce LeveragePRICE SENSITIVE28/02/17
CAJ Final Results for First HalfPRICE SENSITIVE28/02/17
CAJ Appendix 4D and Half Year ResultsPRICE SENSITIVE28/02/17
CAJ China JV - Diagnostic Imaging Consulting/Clinic ManagementPRICE SENSITIVE20/02/17
CAJ Preliminary Unaudited Half Year ResultsPRICE SENSITIVE15/02/17
CAJ Appendix 3B09/01/17
CAJ Response to Government Mid-Year Economic and Fiscal OutlookPRICE SENSITIVE20/12/16
CAJ Capitol receives approval for Full MRI Licence SwapPRICE SENSITIVE16/12/16
CAJ Appendix 3B30/11/16
CAJ Appointment of CFO28/11/16
CAJ Results of Meeting24/11/16
CAJ Managing Directors PresentationPRICE SENSITIVE24/11/16
CAJ Chairman's Address to Shareholders24/11/16
CAJ IDX:Response to speculation on a possible merger acquisition23/11/16
CAJ Market UpdatePRICE SENSITIVE23/11/16
CAJ Appendix 3B22/11/16
CAJ Market UpdatePRICE SENSITIVE15/11/16
CAJ Appointment of Managing DirectorPRICE SENSITIVE11/11/16
CAJ Notice of Annual General Meeting/Proxy Form-CAJ.AX 21/10/16
CAJ Appendix 3Z-CAJ.AX 06/10/16
CAJ Resignation of Managing Director and Interim CEO Appointment-CAJ.AX PRICE SENSITIVE06/10/16
CAJ Executed China Collaboration Agreement with Enlitic-CAJ.AX PRICE SENSITIVE22/09/16
CAJ Market Presentation-CAJ.AX PRICE SENSITIVE29/08/16
CAJ Appendix 4G and Corporate Governance Statement-CAJ.AX 29/08/16
CAJ Annual Report-CAJ.AX 29/08/16
CAJ Appendix 4E-CAJ.AX PRICE SENSITIVE29/08/16
CAJ Appendix 3Z-CAJ.AX 19/08/16
CAJ Final Enlitic Payment-CAJ.AX 15/08/16
CAJ Appendix 3Y-CAJ.AX 08/08/16
CAJ Market update - preliminary results-CAJ.AX PRICE SENSITIVE01/08/16
CAJ Capitol Health MOU with Sunshine Insurance Group-CAJ.AX PRICE SENSITIVE07/06/16
CAJ Capitol Health MOU with CITIC Pharmaceutical-CAJ.AX PRICE SENSITIVE03/06/16
CAJ Notes Information Memorandum & Pricing Supplement-CAJ.AX 28/04/16
CAJ Successful Close of Notes Offering & Financing Update-CAJ.AX 28/04/16
CAJ 4-year senior unsecured notes-CAJ.AX PRICE SENSITIVE21/04/16
CAJ Enlitic payment-CAJ.AX 15/04/16
CAJ Response to ASX Query-CAJ.AX PRICE SENSITIVE13/04/16
CAJ Resignation of Joint Company Secretary31/03/16
CAJ Bell Potter Conference Presentation23/03/16
CAJ S&P DJ Indices Announces March Quarterly Review11/03/16
CAJ Appendix 3Y - John Conidi22/02/16
CAJ Appendix 3Y - Peter Lewis22/02/16
CAJ 3Y - Conidi - 15 Feb 201615/02/16
CAJ Appendix 3B15/02/16
CAJ 3Y - Conidi - 12 Feb 201615/02/16
CAJ Enlitic Shares Acquired11/02/16
CAJ Investor Presentation - February 201608/02/16
CAJ Capitol Health - First Half FY1608/02/16
CAJ Consolidated Interim Financial Report and ASX Appendix 4DPRICE SENSITIVE08/02/16
CAJ Appointment of Non-executive Director23/12/15
CAJ Appointment of Joint Company Secretary22/12/15
CAJ Change of Director's Interest Notice22/12/15
CAJ Response to Government Mid-Year Economic and Fiscal OutlookPRICE SENSITIVE16/12/15
CAJ Change of Director's Interest Notice09/12/15
CAJ Ceasing to be a substantial holder from CAJ27/11/15
CAJ Change of Director's Interest Notice17/11/15
CAJ Results of Meeting16/11/15
CAJ Presentations16/11/15
CAJ Chairman's Address16/11/15
CAJ Change of Director's Interest Notice29/10/15
CAJ Change of Director's Interest Notice28/10/15
CAJ Capitol/Enlitic Alliance to Deliver Better Patient OutcomesPRICE SENSITIVE28/10/15
CAJ Update on Business Activities / Integration27/10/15
CAJ Appendix 3B - Dividend Reinvestment Plan Issue23/10/15
CAJ Capitol completes acquisition of Liverpool Diagnostics19/10/15
CAJ Notice of Annual General Meeting/Proxy Form16/10/15
CAJ Update - Dividend/Distribution - CAJ28/09/15
CAJ Ceasing to be a substantial holder - NAB31/08/15
CAJ Initial Director's Interest Notice31/08/15
CAJ Final Director's Interest Notice31/08/15
CAJ Resignation and Appointment of Directors31/08/15
CAJ Capitol Announces Further Acquisition in NSWPRICE SENSITIVE31/08/15
CAJ Capitol appoints Mr Peter Lewis as Chief Operating Officer18/08/15
CAJ Audit and Risk Committee12/08/15
CAJ FY2015 Full Year Results Presentation11/08/15
CAJ Update on Sale of NSW Assets
19/07/17PRICE SENSITIVE
CAJ Change in substantial holding from WMI
29/06/17
CAJ Change in substantial holding from WAM
26/06/17
CAJ Change in substantial holding from WAA
26/06/17
CAJ Restructuring and Management Changes
16/06/17PRICE SENSITIVE
CAJ Sale of NSW Assets for $81.5m and Guidance
14/06/17PRICE SENSITIVE
CAJ Becoming a substantial holder from WAM
15/05/17
CAJ Becoming a substantial holder from WAA
15/05/17
CAJ Enlitic Wins 1 Million Euro Cube Tech Fair Competition
15/05/17
CAJ Response to Federal Budget Measures
10/05/17
CAJ Ceasing to be a substantial holder
18/04/17
CAJ Market Update
18/04/17PRICE SENSITIVE
CAJ Becoming a substantial holder
13/04/17
CAJ Becoming a substantial holder from AEF
13/04/17
CAJ Placement & SPP Allotment Completed, 3B & Cleansing Notice
11/04/17
CAJ Results of Extraordinary General Meeting
05/04/17
CAJ Enlitic, Capitol & Paiyipai Collaborate in China
03/04/17PRICE SENSITIVE
CAJ Share Purchase Plan Scale-Back Refund
28/03/17
CAJ Share Purchase Plan Oversubscribed
22/03/17
CAJ Waiver from Listing Rule 14.7
14/03/17
CAJ S&P DJ Indices Announces March Quarterly Rebalance
10/03/17PRICE SENSITIVE
CAJ Notice of Extraordinary General Meeting
02/03/17
CAJ SPP Offer Document
02/03/17PRICE SENSITIVE
CAJ Cleansing Notice
02/03/17
CAJ Market Presentation - Results, Capital Raising and SPP
28/02/17
CAJ $38.5m Capital Raising to Reduce Leverage
28/02/17PRICE SENSITIVE
CAJ Final Results for First Half
28/02/17PRICE SENSITIVE
CAJ Appendix 4D and Half Year Results
28/02/17PRICE SENSITIVE
CAJ China JV - Diagnostic Imaging Consulting/Clinic Management
20/02/17PRICE SENSITIVE
CAJ Preliminary Unaudited Half Year Results
15/02/17PRICE SENSITIVE
CAJ Appendix 3B
09/01/17
CAJ Response to Government Mid-Year Economic and Fiscal Outlook
20/12/16PRICE SENSITIVE
CAJ Capitol receives approval for Full MRI Licence Swap
16/12/16PRICE SENSITIVE
CAJ Appendix 3B
30/11/16
CAJ Appointment of CFO
28/11/16
CAJ Results of Meeting
24/11/16
CAJ Managing Directors Presentation
24/11/16PRICE SENSITIVE
CAJ Chairman's Address to Shareholders
24/11/16
CAJ IDX:Response to speculation on a possible merger acquisition
23/11/16
CAJ Market Update
23/11/16PRICE SENSITIVE
CAJ Appendix 3B
22/11/16
CAJ Market Update
15/11/16PRICE SENSITIVE
CAJ Appointment of Managing Director
11/11/16PRICE SENSITIVE
CAJ Notice of Annual General Meeting/Proxy Form-CAJ.AX
21/10/16
CAJ Appendix 3Z-CAJ.AX
06/10/16
CAJ Resignation of Managing Director and Interim CEO Appointment-CAJ.AX
06/10/16PRICE SENSITIVE
CAJ Executed China Collaboration Agreement with Enlitic-CAJ.AX
22/09/16PRICE SENSITIVE
CAJ Market Presentation-CAJ.AX
29/08/16PRICE SENSITIVE
CAJ Appendix 4G and Corporate Governance Statement-CAJ.AX
29/08/16
CAJ Annual Report-CAJ.AX
29/08/16
CAJ Appendix 4E-CAJ.AX
29/08/16PRICE SENSITIVE
CAJ Appendix 3Z-CAJ.AX
19/08/16
CAJ Final Enlitic Payment-CAJ.AX
15/08/16
CAJ Appendix 3Y-CAJ.AX
08/08/16
CAJ Market update - preliminary results-CAJ.AX
01/08/16PRICE SENSITIVE
CAJ Capitol Health MOU with Sunshine Insurance Group-CAJ.AX
07/06/16PRICE SENSITIVE
CAJ Capitol Health MOU with CITIC Pharmaceutical-CAJ.AX
03/06/16PRICE SENSITIVE
CAJ Notes Information Memorandum & Pricing Supplement-CAJ.AX
28/04/16
CAJ Successful Close of Notes Offering & Financing Update-CAJ.AX
28/04/16
CAJ 4-year senior unsecured notes-CAJ.AX
21/04/16PRICE SENSITIVE
CAJ Enlitic payment-CAJ.AX
15/04/16
CAJ Response to ASX Query-CAJ.AX
13/04/16PRICE SENSITIVE
CAJ Resignation of Joint Company Secretary
31/03/16
CAJ Bell Potter Conference Presentation
23/03/16
CAJ S&P DJ Indices Announces March Quarterly Review
11/03/16
CAJ Appendix 3Y - John Conidi
22/02/16
CAJ Appendix 3Y - Peter Lewis
22/02/16
CAJ 3Y - Conidi - 15 Feb 2016
15/02/16
CAJ Appendix 3B
15/02/16
CAJ 3Y - Conidi - 12 Feb 2016
15/02/16
CAJ Enlitic Shares Acquired
11/02/16
CAJ Investor Presentation - February 2016
08/02/16
CAJ Capitol Health - First Half FY16
08/02/16
CAJ Consolidated Interim Financial Report and ASX Appendix 4D
08/02/16PRICE SENSITIVE
CAJ Appointment of Non-executive Director
23/12/15
CAJ Appointment of Joint Company Secretary
22/12/15
CAJ Change of Director's Interest Notice
22/12/15
CAJ Response to Government Mid-Year Economic and Fiscal Outlook
16/12/15PRICE SENSITIVE
CAJ Change of Director's Interest Notice
09/12/15
CAJ Ceasing to be a substantial holder from CAJ
27/11/15
CAJ Change of Director's Interest Notice
17/11/15
CAJ Results of Meeting
16/11/15
CAJ Presentations
16/11/15
CAJ Chairman's Address
16/11/15
CAJ Change of Director's Interest Notice
29/10/15
CAJ Change of Director's Interest Notice
28/10/15
CAJ Capitol/Enlitic Alliance to Deliver Better Patient Outcomes
28/10/15PRICE SENSITIVE
CAJ Update on Business Activities / Integration
27/10/15
CAJ Appendix 3B - Dividend Reinvestment Plan Issue
23/10/15
CAJ Capitol completes acquisition of Liverpool Diagnostics
19/10/15
CAJ Notice of Annual General Meeting/Proxy Form
16/10/15
CAJ Update - Dividend/Distribution - CAJ
28/09/15
CAJ Ceasing to be a substantial holder - NAB
31/08/15
CAJ Initial Director's Interest Notice
31/08/15
CAJ Final Director's Interest Notice
31/08/15
CAJ Resignation and Appointment of Directors
31/08/15
CAJ Capitol Announces Further Acquisition in NSW
31/08/15PRICE SENSITIVE
CAJ Capitol appoints Mr Peter Lewis as Chief Operating Officer
18/08/15
CAJ Audit and Risk Committee
12/08/15
CAJ FY2015 Full Year Results Presentation
11/08/15
refresh Created with Sketch. REFRESH
 
(20min delay)
Last
38.0¢ 		Change
0.000(0.00%) 		Mkt cap ! $341.1M
Open High Low Value Volume
39.0¢ 39.0¢ 38.0¢ $1.386M 3.623M

Buyers (Bids)

No. Vol. Price($)
1 6291 38.0¢
 

Sellers (Offers)

Price($) Vol. No.
39.0¢ 1657545 14
View Market Depth
Last trade - 16.10pm 15/11/2024 (20 minute delay) ?
Last
38.3¢ 		  Change
0.000 ( 0.63 %)
Open High Low Volume
38.0¢ 38.3¢ 38.0¢ 113461
Last updated 14.17pm 15/11/2024 ?
CAJ (ASX) Chart

Top Stories

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

Put simply: if 3D Printing is a gold rush, Amaero is selling shovels. Or maybe it's more like sneakers in an arms race.
Week 46 Wrap: Copper hits 2mth low as Trump threatens net zero pace; US rally fades; HotCopper’s picks Copper prices slump; Trump Wall Street rally fades; US health stocks dip on RFK appointment – and much more.
Blue Star Helium sees approval for five more wells at 'Galactica/Pegasus' project in Colorado Blue Star Helium (ASX:BNL) has won approval from Colorado regulators to drill five fresh helium wells at its flagship.
Banshee's historic trenches prove rich in antimony and gold for GDM Great Divide Mining Ltd has found high-grade antimony and gold through geochemical sampling at its Banshee prospect in Queensland
CuFe sells its Crossroads gold royalty to Northern Star for $4M cash; says better than waiting for mine launch CuFe Ltd (ASX:CUF) has decided not to wait around for Northern Star's Crossroads mine to get up and running, selling its $4M royalty right.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.